Bio-Rad Laboratories (BIO-B) Other financing activities (2009 - 2024)
Bio-Rad Laboratories (BIO-B) reported Other financing activities of $600000.0 for Q1 2024, up 2042.86% on a QoQ basis from $28000.0 in Q3 2019.
Bio-Rad Laboratories (BIO-B) has 10 years of Other financing activities data on file, last reported at $600000.0 in Q1 2024.
- Quarterly Other financing activities changed N/A year-over-year to $600000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $600000.0 (changed N/A YoY) and the FY2024 annual result came in at $600000.0, changed N/A from the prior year.
- Other financing activities rose to $600000.0 in Q1 2024 per BIO-B's latest filing, from $28000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $600000.0 in Q1 2024 and bottomed at $600000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Sep 30, 2019 | 28,000.00 |
| Sep 30, 2019 | 28,000.00 |
| Dec 31, 2016 | 412,000.00 |
| Dec 31, 2016 | 412,000.00 |
| Sep 30, 2016 | 1.02 Mn |
| Sep 30, 2016 | 1.02 Mn |
| Jun 30, 2016 | 8,000.00 |
| Jun 30, 2016 | 8,000.00 |
| Mar 31, 2016 | 67,000.00 |
| Mar 31, 2016 | 67,000.00 |
| Dec 31, 2015 | 368,000.00 |
| Dec 31, 2015 | 368,000.00 |
| Sep 30, 2015 | 1.98 Mn |
| Sep 30, 2015 | 1.98 Mn |
| Jun 30, 2015 | 46,000.00 |
| Jun 30, 2015 | 46,000.00 |
| Mar 31, 2015 | 1.21 Mn |
| Mar 31, 2015 | 1.21 Mn |
| Dec 31, 2014 | 583,000.00 |
| Dec 31, 2014 | 583,000.00 |
| Sep 30, 2014 | 303,000.00 |
| Sep 30, 2014 | 303,000.00 |
| Jun 30, 2014 | 281,000.00 |
| Jun 30, 2014 | 281,000.00 |
| Mar 31, 2014 | 182,000.00 |
| Mar 31, 2014 | 182,000.00 |
| Dec 31, 2013 | 1.89 Mn |
| Dec 31, 2013 | 1.89 Mn |
| Sep 30, 2013 | 309,000.00 |
| Sep 30, 2013 | 309,000.00 |
| Jun 30, 2013 | 393,000.00 |
| Jun 30, 2013 | 393,000.00 |
| Mar 31, 2013 | 106,000.00 |
| Mar 31, 2013 | 106,000.00 |
| Dec 31, 2012 | -925,000.00 |
| Dec 31, 2012 | -925,000.00 |
| Sep 30, 2012 | 376,000.00 |
| Sep 30, 2012 | 376,000.00 |
| Jun 30, 2012 | 208,000.00 |
| Jun 30, 2012 | 208,000.00 |
| Mar 31, 2012 | 341,000.00 |
| Mar 31, 2012 | 341,000.00 |
| Sep 30, 2011 | -1.53 Mn |
| Sep 30, 2011 | -1.53 Mn |
| Jun 30, 2011 | 1.53 Mn |
| Jun 30, 2011 | 1.53 Mn |
| Mar 31, 2011 | 242,000.00 |
| Mar 31, 2011 | 242,000.00 |
| Dec 31, 2010 | 244,000.00 |
| Dec 31, 2010 | 244,000.00 |
| Sep 30, 2010 | 2.11 Mn |
| Sep 30, 2010 | 2.11 Mn |
| Jun 30, 2010 | 352,000.00 |
| Jun 30, 2010 | 352,000.00 |
| Mar 31, 2010 | 223,000.00 |
| Mar 31, 2010 | 223,000.00 |
| Dec 31, 2009 | 2.26 Mn |
| Dec 31, 2009 | 2.26 Mn |
| Sep 30, 2009 | 468,000.00 |
| Sep 30, 2009 | 468,000.00 |